reimbursement

News

Santhera's DMD drug poised for wider rollout in Germany

Santhera has agreed pricing and reimbursement for its Duchenne muscular dystrophy drug Agamree with German health funds representing 90% of patients.

Market Access

Part One: Overcoming challenges and seizing opportunities in...

The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked condi

News

BioMarin keeps but scales down Roctavian gene therapy ops

BioMarin Pharma has decided not to divest its haemophilia A gene therapy Roctavian, which has struggled to build much traction in the market, but is reining back its ambitions for the busin

News

House committee backs some Medicare cover for obesity drugs

The House Ways and Means Committee in the US voted in favour of a new bill which would end a two-decade-long restriction on the coverage of drugs to treat obesity under Medicare.

News

England, Denmark back CSL’s haemophilia B gene therapy

It has been a good week for CSL Behring as it rolls out haemophilia B gene therapy Hemgenix, with positive reimbursement decisions in both the UK and Denmark.

News

Mahana’s DTx for IBS gets permanent reimbursement in Germany

Mahana Therapeutics has been granted permanent reimbursement in Germany for its Cara Care for irritable bowel syndrome (IBS), paving the way for greater patient access to the digital therap

Santhera's DMD drug poised for wider rollout in Germany

Part One: Overcoming challenges and seizing opportunities in...

BioMarin keeps but scales down Roctavian gene therapy ops

House committee backs some Medicare cover for obesity drugs

England, Denmark back CSL’s haemophilia B gene therapy

Mahana’s DTx for IBS gets permanent reimbursement in Germany

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

reimbursement

Editor's Picks